Concepedia

Apinya Vutikullird

AV

Statistics

Publications

7

Citations

376

H-Index

7

Active since

2010

Affiliations

Bristol-Myers Squibb (United States)(Current)

Apinya Vutikullird is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, pharmacology, and drug resistance.

Top concepts

Publications per year

2010–2019

7

Publications

7

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

Richard E. Nettles, Min Gao, Marc Bifano et al. · Hepatology · 2010 · 177 citations · Full text

Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies

Alison E. Heald, Patrick L. Iversen, Jay Saoud et al. · Antimicrobial Agents and Chemotherapy · 2014 · 82 citations · Full text

, , +17

Randomized, Placebo-Controlled, Single-Ascending-Dose Study of BMS-791325, a Hepatitis C Virus (HCV) NS5B Polymerase Inhibitor, in HCV Genotype 1 Infection

Karen Sims, Julie A. Lemm, Timothy Eley et al. · Antimicrobial Agents and Chemotherapy · 2014 · 32 citations · Full text

Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects

David L. Dai, Hua Yang, Salah Nabhan et al. · European Journal of Clinical Pharmacology · 2019 · 30 citations · Full text

A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL‐1401O <i>vs</i>. EU‐trastuzumab and US‐trastuzumab

Cornelius F. Waller, Apinya Vutikullird, Tracey E. Lawrence et al. · British Journal of Clinical Pharmacology · 2018 · 29 citations · Full text

1–5 of 7